Fetal Growth and Risk of Stillbirth: A Population-Based Case–Control Study
Background:
Stillbirth is strongly related to impaired fetal growth. However, the relationship between fetal growth and stillbirth is difficult to determine because of uncertainty in the timing of death and confounding characteristics affecting normal fetal growth.
Methods and Findings:
We conducted a population-based case–control study of all stillbirths and a representative sample of live births in 59 hospitals in five geographic areas in the US. Fetal growth abnormalities were categorized as small for gestational age (SGA) (<10th percentile) or large for gestational age (LGA) (>90th percentile) at death (stillbirth) or delivery (live birth) using population, ultrasound, and individualized norms. Gestational age at death was determined using an algorithm that considered the time-of-death interval, postmortem examination, and reliability of the gestational age estimate. Data were weighted to account for the sampling design and differential participation rates in various subgroups. Among 527 singleton stillbirths and 1,821 singleton live births studied, stillbirth was associated with SGA based on population, ultrasound, and individualized norms (odds ratio [OR] [95% CI]: 3.0 [2.2 to 4.0]; 4.7 [3.7 to 5.9]; 4.6 [3.6 to 5.9], respectively). LGA was also associated with increased risk of stillbirth using ultrasound and individualized norms (OR [95% CI]: 3.5 [2.4 to 5.0]; 2.3 [1.7 to 3.1], respectively), but not population norms (OR [95% CI]: 0.6 [0.4 to 1.0]). The associations were stronger with more severe SGA and LGA (<5th and >95th percentile). Analyses adjusted for stillbirth risk factors, subset analyses excluding potential confounders, and analyses in preterm and term pregnancies showed similar patterns of association. In this study 70% of cases and 63% of controls agreed to participate. Analysis weights accounted for differences between consenting and non-consenting women. Some of the characteristics used for individualized fetal growth estimates were missing and were replaced with reference values. However, a sensitivity analysis using individualized norms based on the subset of stillbirths and live births with non-missing variables showed similar findings.
Conclusions:
Stillbirth is associated with both growth restriction and excessive fetal growth. These findings suggest that, contrary to current practices and recommendations, stillbirth prevention strategies should focus on both severe SGA and severe LGA pregnancies.
Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Fetal Growth and Risk of Stillbirth: A Population-Based Case–Control Study. PLoS Med 11(4): e32767. doi:10.1371/journal.pmed.1001633
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001633
Souhrn
Background:
Stillbirth is strongly related to impaired fetal growth. However, the relationship between fetal growth and stillbirth is difficult to determine because of uncertainty in the timing of death and confounding characteristics affecting normal fetal growth.
Methods and Findings:
We conducted a population-based case–control study of all stillbirths and a representative sample of live births in 59 hospitals in five geographic areas in the US. Fetal growth abnormalities were categorized as small for gestational age (SGA) (<10th percentile) or large for gestational age (LGA) (>90th percentile) at death (stillbirth) or delivery (live birth) using population, ultrasound, and individualized norms. Gestational age at death was determined using an algorithm that considered the time-of-death interval, postmortem examination, and reliability of the gestational age estimate. Data were weighted to account for the sampling design and differential participation rates in various subgroups. Among 527 singleton stillbirths and 1,821 singleton live births studied, stillbirth was associated with SGA based on population, ultrasound, and individualized norms (odds ratio [OR] [95% CI]: 3.0 [2.2 to 4.0]; 4.7 [3.7 to 5.9]; 4.6 [3.6 to 5.9], respectively). LGA was also associated with increased risk of stillbirth using ultrasound and individualized norms (OR [95% CI]: 3.5 [2.4 to 5.0]; 2.3 [1.7 to 3.1], respectively), but not population norms (OR [95% CI]: 0.6 [0.4 to 1.0]). The associations were stronger with more severe SGA and LGA (<5th and >95th percentile). Analyses adjusted for stillbirth risk factors, subset analyses excluding potential confounders, and analyses in preterm and term pregnancies showed similar patterns of association. In this study 70% of cases and 63% of controls agreed to participate. Analysis weights accounted for differences between consenting and non-consenting women. Some of the characteristics used for individualized fetal growth estimates were missing and were replaced with reference values. However, a sensitivity analysis using individualized norms based on the subset of stillbirths and live births with non-missing variables showed similar findings.
Conclusions:
Stillbirth is associated with both growth restriction and excessive fetal growth. These findings suggest that, contrary to current practices and recommendations, stillbirth prevention strategies should focus on both severe SGA and severe LGA pregnancies.
Please see later in the article for the Editors' Summary
Zdroje
1. MacDormanMF, KirmeyerS (2009) Fetal and perinatal mortality, United States, 2005. Natl Vital Stat Rep 57: 1–19.
2. MacDormanMF, MathewsTJ (2008) Recent trends in infant mortality in the United States. NCHS Data Brief 1–8.
3. LawnJE, BlencoweH, PattinsonR, CousensS, KumarR, et al. (2011) Stillbirths: Where? When? Why? How to make the data count? Lancet 377: 1448–1463 doi:10.1016/S0140-6736(10)62187-3
4. StantonC, LawnJE, RahmanH, Wilczynska-KetendeK, HillK (2006) Stillbirth rates: delivering estimates in 190 countries. Lancet 367: 1487–1494 doi:10.1016/S0140-6736(06)68586-3
5. FlenadyV, KoopmansL, MiddletonP, FroenJF, SmithGC, et al. (2011) Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet 377: 1331–1340 doi:10.1016/S0140-6736(10)62233-7
6. SmithGC, FrettsRC (2007) Stillbirth. Lancet 370: 1715–1725 doi:10.1016/S0140-6736(07)61723-1
7. ACOG practice bulletin. Antepartum fetal surveillance. Number 9, October 1999 (replaces Technical Bulletin Number 188, January 1994). Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 68: 175–185.
8. Royal College of Obstetricians and Gynaecologists (2010) Late intrauterine fetal death and stillbirth. RCOG Green-top Guideline No. 55. London: Royal College of Obstetricians and Gynaecologists.
9. ListonR, SawchuckD, YoungD (2007) Fetal health surveillance: antepartum and intrapartum consensus guideline. Society of Obstetricians and Gynaecologists of Canada. J Obstet Gynaecol Can 29: S3–56.
10. Royal Australian and New Zealand College of Obstetricians and Gynaecologists (2009) Intrapartum fetal surveillance clinical guidelines—second edition. East Melbourne: Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
11. SmithGC, ShahI, WhiteIR, PellJP, CrossleyJA, et al. (2007) Maternal and biochemical predictors of antepartum stillbirth among nulliparous women in relation to gestational age of fetal death. BJOG 114: 705–714 doi:10.1111/j.1471-0528.2007.01343.x
12. SmithGC, CrossleyJA, AitkenDA, PellJP, CameronAD, et al. (2004) First-trimester placentation and the risk of antepartum stillbirth. JAMA 292: 2249–2254 doi:10.1001/jama.292.18.2249
13. SpencerK (2000) Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome. Prenat Diagn 20: 652–656.
14. YaronY, CherryM, KramerRL, O'BrienJE, HallakM, et al. (1999) Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol 181: 968–974.
15. BukowskiR, UchidaT, SmithGC, MaloneFD, BallRH, et al. (2008) Individualized norms of optimal fetal growth: fetal growth potential. Obstet Gynecol 111: 1065–1076 doi:10.1097/AOG.0b013e3181704e48
16. ParkerCB, HogueCJ, KochMA, WillingerM, ReddyUM, et al. (2011) Stillbirth Collaborative Research Network: design, methods and recruitment experience. Paediatr Perinat Epidemiol 25: 425–435 doi:10.1111/j.1365-3016.2011.01218.x
17. ConwayDL, HansenNI, DudleyDJ, ParkerCB, ReddyUM, et al. (2013) An algorithm for the estimation of gestational age at the time of fetal death. Paediatr Perinat Epidemiol 27: 145–157 doi:10.1111/ppe.12037
18. AlexanderGR, HimesJH, KaufmanRB, MorJ, KoganM (1996) A United States national reference for fetal growth. Obstet Gynecol 87: 163–168 doi:10.1016/0029-7844(95)00386-X
19. HadlockFP, HarristRB, Martinez-PoyerJ (1991) In utero analysis of fetal growth: a sonographic weight standard. Radiology 181: 129–133.
20. GardosiJ, ChangA, KalyanB, SahotaD, SymondsEM (1992) Customised antenatal growth charts. Lancet 339: 283–287.
21. Stillbirth Collaborative Research Network (2011) Association between stillbirth and risk factors known at pregnancy confirmation. JAMA 306: 2469–2479 doi:10.1001/jama.2011.1798
22. BorrellC, CireraE, RicartM, PasarinMI, SalvadorJ (2003) Social inequalities in perinatal mortality in a southern European city. Eur J Epidemiol 18: 5–13.
23. CanterinoJC, AnanthCV, SmulianJ, HarriganJT, VintzileosAM (2004) Maternal age and risk of fetal death in singleton gestations: USA, 1995–2000. J Matern Fetal Neonatal Med 15: 193–197 doi:10.1080/14767050410001668301
24. CnattingiusS, HaglundB, KramerMS (1998) Differences in late fetal death rates in association with determinants of small for gestational age fetuses: population based cohort study. BMJ 316: 1483–1487.
25. HutcheonJA, ZhangX, CnattingiusS, KramerMS, PlattRW (2008) Customised birthweight percentiles: does adjusting for maternal characteristics matter? BJOG 115: 1397–1404 doi:10.1111/j.1471-0528.2008.01870.x
26. ZhangX, PlattRW, CnattingiusS, JosephKS, KramerMS (2007) The use of customised versus population-based birthweight standards in predicting perinatal mortality. BJOG 114: 474–477 doi:10.1111/j.1471-0528.2007.01273.x
27. RayJG, UrquiaML (2012) Risk of stillbirth at extremes of birth weight between 20 to 41 weeks gestation. J Perinatol 32: 829–836 doi:10.1038/jp.2012.60
28. ClaussonB, GardosiJ, FrancisA, CnattingiusS (2001) Perinatal outcome in SGA births defined by customised versus population-based birthweight standards. BJOG 108: 830–834.
29. FroenJF, GardosiJO, ThurmannA, FrancisA, Stray-PedersenB (2004) Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand 83: 801–807 doi:10.1111/j.0001-6349.2004.00602.x
30. GardosiJ, MulT, MongelliM, FaganD (1998) Analysis of birthweight and gestational age in antepartum stillbirths. Br J Obstet Gynaecol 105: 524–530.
31. GenestDR, SingerDB (1992) Estimating the time of death in stillborn fetuses: III. External fetal examination; a study of 86 stillborns. Obstet Gynecol 80: 593–600.
32. GenestDR (1992) Estimating the time of death in stillborn fetuses: II. Histologic evaluation of the placenta; a study of 71 stillborns. Obstet Gynecol 80: 585–592.
33. GenestDR, WilliamsMA, GreeneMF (1992) Estimating the time of death in stillborn fetuses: I. Histologic evaluation of fetal organs; an autopsy study of 150 stillborns. Obstet Gynecol 80: 575–584.
34. ZhangX, DeckerA, PlattRW, KramerMS (2008) How big is too big? The perinatal consequences of fetal macrosomia. Am J Obstet Gynecol 198: 517.e1–6 doi:10.1016/j.ajog.2007.12.005
35. SmithGC (2001) Life-table analysis of the risk of perinatal death at term and post term in singleton pregnancies. Am J Obstet Gynecol 184: 489–496 doi:10.1067/mob.2001.109735
36. BurmeisterB, ZaleskiC, ColdC, McPhersonE (2012) Wisconsin Stillbirth Service Program: analysis of large for gestational age cases. Am J Med Genet A 158A: 2493–2498 doi:10.1002/ajmg.a.35578
37. PolakowskiLL, AkinbamiLJ, MendolaP (2009) Prenatal smoking cessation and the risk of delivering preterm and small-for-gestational-age newborns. Obstet Gynecol 114: 318–325 doi:10.1097/AOG.0b013e3181ae9e9c
38. CastlesA, AdamsEK, MelvinCL, KelschC, BoultonML (1999) Effects of smoking during pregnancy. Five meta-analyses. Am J Prev Med 16: 208–215.
39. GibbonsK, ChangA, FlenadyV, MahomedK, GardenerG, et al. (2013) Customised birthweight models: do they increase identification of at-risk infants? J Paediatr Child Health 49: 380–387 doi:10.1111/jpc.12189
40. CarberryAE, GordonA, BondDM, HyettJ, Raynes-GreenowCH, et al. (2011) Customised versus population-based growth charts as a screening tool for detecting small for gestational age infants in low-risk pregnant women. Cochrane Database Syst Rev 2011: CD008549 doi:10.1002/14651858.CD008549.pub2
41. GibbonsKS, ChangAM, FlenadyVJ, MahomedK, GrayPH, et al. (2013) A test of agreement of customised birthweight models. Paediatr Perinat Epidemiol 27: 131–137 doi:10.1111/ppe.12041
42. Committee on Practice Bulletins—Obstetrics (2013) Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol 122: 406–416 doi:10.1097/01.AOG.0000433006.09219.f1
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2014 Číslo 4
- Pleiotropní účinky statinů na kardiovaskulární systém
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- Intermitentní hladovění v prevenci a léčbě chorob
- Co dělat při intoleranci statinů?
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
Najčítanejšie v tomto čísle
- Burden of Total and Cause-Specific Mortality Related to Tobacco Smoking among Adults Aged ≥45 Years in Asia: A Pooled Analysis of 21 Cohorts
- What We Know and What We Don't Know About Preventing Stroke
- Safety of Pediatric HIV Elimination: The Growing Population of HIV- and Antiretroviral-Exposed but Uninfected Infants
- Regional Changes in Charcoal-Burning Suicide Rates in East/Southeast Asia from 1995 to 2011: A Time Trend Analysis